BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

May 31, 2023 | News

Leading New Zealand Cancer Research Gets a Data Privacy Boost with Amaroq Therapeutics and GeneCrypt Partnership

Amaroq Therapeutics, a world-leading company based in New Zealand focused on developing a new class of therapeutics that targets long non-coding ...

May 26, 2023 | News

Formus Labs Receives FDA Clearance for AI-Powered Orthopedic Surgery Planning Technology.

Formus Labs today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Formus Hip as th...

May 04, 2023 | News

Why Pharma and Medtech manufacturers are striving for digital maturity

Why pharma and medtech manufacturers are striving for...

April 25, 2023 | News

Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics

The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...

April 12, 2023 | News

Earable Neuroscience and Excelpoint Partner to Commercialize AI-Powered FRENZ Brainband for Global Sleep Pandemic

Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and qualit...

March 31, 2023 | News

Orion Health strengthens North American operations with new technology and leadership

Orion Health, a global leader in population health software, is strengthening its position in North America with new technology and the appointme...

March 25, 2023 | News

See-Mode Technologies' AI-powered Ultrasound Software Secures Regulatory Approval in Australia and New Zealand.

"We are thrilled to receive regulatory approvals for our product in Australia and New Zealand," said Dr Milad Mohammadzadeh, Co-Founder...

March 22, 2023 | News

Precision Medicine Takes Center Stage: Exploring the Innovative Biopharma Industry in Australia and New Zealand

Australia and New Zealand have always been at the forefront of innovation and research in the biopharma industry. The region's strategic location and stron...

February 24, 2023 | News

Chrysalis Advisory and TriNetX collaborate to aid research teams in Australia and New Zealand

The goal of the collaboration is to extend the availability of consulting services to healthcare organizations in the region who are in need of assistance ...

February 22, 2023 | News

Global Sarcoma Therapy Now Approved for New Zealand Patients

Globally regarded soft-tissue sarcoma therapy has been approved by Medsafe for New Zealand patients YONDELIS® (trabectedin) demonstra...

February 18, 2023 | News

6 Ways Digitisation Drives Pharma Success

Modern manufacturing integrations and connected cloud-based manufacturing execution systems (MES) are giving pharma leaders a competitive edge. In this web...

January 28, 2023 | News

New Zealand to host first-ever country pavilion at Arab Health 2023 as regional interest in its world-class health tech innovations grows

Led by New Zealand Trade and Enterprise (NZTE), the New Zealand Government's international economic development agency charged with growing companies ...

January 26, 2023 | News

Pictor announces important COVID-19 trial to map immunity profile of New Zealanders

Pictor, a global leader in immunodiagnostics, today announced an important research project – the Pictor Antibody Clinical Trial (PACT-19) – wh...

December 22, 2022 | News

Stay Connected